In line with this, transwell experiments revealed that tumor‐infiltrating CD8+ T‐cells from fresh CRC tissues with mutant KRAS versus those with wild‐type KRAS had similar migrating abilities (Figure4A). The gene discussed is CD8A; the disease is neoplasm.